Carefully administer Hepapac to patients with chronic active hepatitis and cirrhosis. There are few cases where patients decrease alanine transaminase (ALT) levels during therapy. After discontinuation of Hepapac, ALT levels may increase but re-administration may improve it.
Use in pregnancy & lactation: Caution should be observed when using Hepapac to pregnant and breastfeeding women.